Cargando…
ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration
PURPOSE: To determine the association of age-related maculopathy susceptibility 2 (ARMS2) gene polymorphisms with the 3-year outcomes of photodynamic therapy (PDT) in wet age-related macular degeneration (wet AMD). METHODS: The single nucleotide polymorphism (SNP) at rs10490924 in the ARMS2 gene of...
Autores principales: | Nakai, Shunichiro, Honda, Shigeru, Matsumiya, Wataru, Miki, Akiko, Nakamura, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534487/ https://www.ncbi.nlm.nih.gov/pubmed/28761324 |
Ejemplares similares
-
Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy
por: Hayashida, Mayuka, et al.
Publicado: (2020) -
A Common Complement C3 Variant Is Associated with Protection against Wet Age-Related Macular Degeneration in a Japanese Population
por: Yanagisawa, Suiho, et al.
Publicado: (2011) -
Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2)
por: Yanagisawa, Suiho, et al.
Publicado: (2011) -
Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity
por: Hayashida, Mayuka, et al.
Publicado: (2020) -
Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
por: Hirose, Miki, et al.
Publicado: (2014)